Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β

Oncotarget

Volumn 6, Issue 12, 2015, Pages 9781-9793

  Zhao, Liang ^a   Lin, Li ^a   Pan, Changqie ^a   Shi, Min ^a   Liao, Yulin ^a   Bin, Jianping ^a   Liao, Wangjun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Flotillin 2; Metastasis; Nasopharyngeal carcinoma; Transforming growth factor

Indexed keywords

BETA CATENIN; FLOTILLIN 2; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; BIOLOGICAL MARKER; CADHERIN; CDH1 PROTEIN, HUMAN; FLOTILLINS; MEMBRANE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CELL MOTILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE DELETION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; NASOPHARYNX; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; AGED; CELL MEMBRANE; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR CELL LINE; WOUND HEALING;

AGED; BIOMARKERS; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 84929600772     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3382     Document Type: Article

References (23)

1. Ungefroren H, Sebens S, Groth S, Gieseler F, Fandrich F. Differential roles of Src in transforming growth factor-ss regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells. Int J Oncol. 2011; 3:797-805.
2. Pignatelli J, Tumbarello DA, Schmidt RP, Turner CE. Hic-5 promotes invadopodia formation and invasion during TGFbeta-induced epithelial-mesenchymal transition. J Cell Biol. 2012; 3:421-37.
3. Bertran E, Crosas-Molist E, Sancho P, Caja L, Lopez-Luque J, Navarro E, Egea G, Lastra R, Serrano T, Ramos E, Fabregat I. Overactivation of the TGF-beta pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells. Hepatology. 2013; 6:2032-44.
4. Heldin CH, Vanlandewijck M, Moustakas A. Regulation of EMT by TGFbeta in cancer. FEBS Lett. 2012; 14:1959-70.
5. Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007; 10:1512-20.
6. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL. Activation of the Erk pathway is required for TGFbeta1-induced EMT in vitro. Neoplasia. 2004; 5:603-10.
7. Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL. Inhibition of TGF-beta with neutralizing antibodies prevents radiationinduced acceleration of metastatic cancer progression. J Clin Invest. 2007; 5:1305-13.
8. Pickup M, Novitskiy S, Moses HL. The roles of TGFbeta in the tumour microenvironment. Nat Rev Cancer. 2013; 11:788-99.
9. Bierie B, Moses HL. TGF-beta and cancer. Cytokine Growth Factor Rev. 2006; 1-2:29-40.
10. Samant RS, Shevde LA. NMI and EMT. Oncoscience. 2014; 7:476-7.
11. Geng J, Fan J, Ouyang Q, Zhang X, Yu J, Xu Z, Li Q, Yao X, Liu X, Zheng J. Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-beta/Smad signaling pathway. Oncotarget. 2014; 14:5700-11.
12. Chan AT. Nasopharyngeal carcinoma. Ann Oncol. 2010; vii308-12.
13. Pust S, Klokk TI, Musa N, Jenstad M, Risberg B, Erikstein B, Tcatchoff L, Liestol K, Danielsen HE, van Deurs B, Sandvig K. Flotillins as regulators of ErbB2 levels in breast cancer. Oncogene. 2013; 29:3443-51.
14. Stuermer CA, Lang DM, Kirsch F, Wiechers M, Deininger SO, Plattner H. Glycosylphosphatidyl inositolanchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and-2. Mol Biol Cell. 2001; 10:3301-45.
15. Lang DM, Lommel S, Jung M, Ankerhold R, Petrausch B, Laessing U, Wiechers MF, Plattner H, S CA. Identification of reggie-1 and reggie-2 as plasma membrane-associated proteins which co-cluster with activated GPI-anchored cell adhesion molecules in non-caveolar microdomains in neurons. J Neurobiol. 1998; 4:502-23.
16. Ludwig A, Otto GP, Riento K, Hams E, Fallon PG, N BJ. Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment. J Cell Biol. 2010; 4:771-81.
17. Hazarika P1, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M, Duvic M. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res. 2004; 20:7361-9.
18. Berger T, Ueda T, Arpaia E, Chio LL, Shirdel EA, Jurisica I, Hamada K, You-Ten A, Haight J, Wakeham A, Cheung CC, Mak TW. Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model. Oncogene. 2013; 41:4989-94.
19. Wen Q, Li J, Wang W, Xie G, Xu L, Luo J, Chu S, She L, Li D, Huang D, Fan S. Increased Expression of Flotillin-2 Protein as a Novel Biomarker for Lymph Node Metastasis in Nasopharyngeal Carcinoma. PLoS One. 2014; 7.
20. Koch JC, Solis GP, Bodrikov V, Michel U, Haralampieva D, Shypitsyna A, Tonges L, Bahr M, Lingor P, Stuermer CA. Upregulation of reggie-1/flotillin-2 promotes axon regeneration in the rat optic nerve in vivo and neurite growth in vitro. Neurobiol Dis. 2013; 168-76.
21. Zhu Z, Wang J, Sun Z, Sun X, Wang Z, X H. Flotillin2 expression correlates with HER2 levels and poor prognosis in gastric cancer. PLoS One. 2013; 5.
22. Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, Moses HL. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res. 2004; 3:R215-31.
23. Lin L, Huang H, Liao W, Ma H, Liu J, Wang L, Huang N, Liao Y. MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene. 2014; doi: 10.1038/ONC.2014.1204.